Progressive burden of myelofibrosis in untreated patients: Assessment of patient-reported outcomes in patients randomized to placebo in the COMFORT-I study

导出原文传递

翻译打印收藏纠错

作者： Mesa,R.A. ^[1] ; Shields,A. ^[2] ; Hare,T. ^[3] ; Erickson-Viitanen,S. ^[4] ; Sun,W. ; Sarlis,N.J. ; Sandor,V. ; Levy,R.S. ; Verstovsek,S.

作者单位： MD Anderson Cancer Center, Houston, TX, United States ^[1] Adelphi Values, Boston, MA, United States ^[2] Incyte Corporation, Wilmington, DE, United States ^[3] Mayo Clinic, Scottsdale, AZ, United States ^[4]

关键词 Fatigue Myelofibrosis Patient-reported outcomes Quality of life Ruxolitinib Splenomegaly

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Leukemia Research

2013年37卷8期

911-916页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Progressive burden of myelofibrosis in untreated patients: Assessment of patient-reported outcomes in patients randomized to placebo in the COMFORT-I study

Leukemia Research

相似文献

Leukemia Research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Progressive burden of myelofibrosis in untreated patients: Assessment of patient-reported outcomes in patients randomized to placebo in the COMFORT-I study

Leukemia Research

相似文献

Leukemia Research

相关期刊

检索历史清除